Ursula von der Leyen (REUTERS/Dado Ruvic/Illustration)

The European Medicines Agency (EMA) does not have enough data on the safety of the Russian Sputnik V coronavirus vaccine to register the drug in the European Union. This was stated by the President of the European Commission (EC) Ursula von der Leyen.

“It became very quiet around Sputnik. The application to the EMA was filed a long time ago. However, the supplier has not yet provided sufficient reliable data to support the safety. This raises questions, ”said von der Leyen. She is quoted by the media group Redaktionsnetzwerk Deutschland.

For its part, the press service of the Russian Direct Investment Fund (RDIF), which participated in the development of the drug, reported that the approval process for Sputnik V in EMA is proceeding in a positive and professional manner.


In turn, Russian Foreign Minister Sergei Lavrov said that the agency “remarks to the vaccine itself and its degree of effectiveness is not”.

“We proceed from the fact that the issue is in the plane of a depoliticized and professional dialogue between specialized structures,” added the head of the Russian Foreign Ministry.

At the same time, Lavrov noted that “with the wider use of Sputnik V by individual representatives of the EU and its member states, the degree of aggressive rhetoric is increasing.”


Public Reaction